Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Digital Health Technologies for Alzheimer's Disease and Related Dementias: Initial Results from a Landscape Analysis and Community Collaborative Effort.
Lott SA, Streel E, Bachman SL, Bode K, Dyer J, Fitzer-Attas C, Goldsack JC, Hake A, Jannati A, Fuertes RS, Fromy P. Lott SA, et al. Among authors: fitzer attas c. J Prev Alzheimers Dis. 2024;11(5):1480-1489. doi: 10.14283/jpad.2024.103. J Prev Alzheimers Dis. 2024. PMID: 39350395 Free PMC article. Review.
Verification, analytical validation, and clinical validation (V3): the foundation of determining fit-for-purpose for Biometric Monitoring Technologies (BioMeTs).
Goldsack JC, Coravos A, Bakker JP, Bent B, Dowling AV, Fitzer-Attas C, Godfrey A, Godino JG, Gujar N, Izmailova E, Manta C, Peterson B, Vandendriessche B, Wood WA, Wang KW, Dunn J. Goldsack JC, et al. Among authors: fitzer attas c. NPJ Digit Med. 2020 Apr 14;3:55. doi: 10.1038/s41746-020-0260-4. eCollection 2020. NPJ Digit Med. 2020. PMID: 32337371 Free PMC article. Review.
Utility of Huntington's Disease Assessments by Disease Stage: Floor/Ceiling Effects.
Abreu D, Ware J, Georgiou-Karistianis N, Leavitt BR, Fitzer-Attas CJ, Lobo R, Fernandes AR, Handley O, Anderson KE, Stout JC, Sampaio C. Abreu D, et al. Among authors: fitzer attas cj. Front Neurol. 2021 Jul 15;12:595679. doi: 10.3389/fneur.2021.595679. eCollection 2021. Front Neurol. 2021. PMID: 34335433 Free PMC article.
Toward e-Scales: Digital Administration of the International Parkinson and Movement Disorder Society Rating Scales.
Monje MHG, Fuller RLM, Cubo E, Mestre TA, Tan AH, Stout JC, Ali S, Chahine L, Dujardin K, Fitzer-Attas CJ, Youn J, Bloem BR, Horak FB, Merola A, Reilmann R, Paul SS, Dorsey ER, Maetzler W, Espay AJ, Martinez-Martin P, Stebbins GT, Sánchez-Ferro Á; MDS Rating Scales Program Electronic Development Committee and the MDS Technology Taskforce. Monje MHG, et al. Among authors: fitzer attas cj. Mov Disord Clin Pract. 2020 Dec 28;8(2):208-214. doi: 10.1002/mdc3.13135. eCollection 2021 Feb. Mov Disord Clin Pract. 2020. PMID: 33553489 Free PMC article. No abstract available.
PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease Progression.
Fazio P, Fitzer-Attas CJ, Mrzljak L, Bronzova J, Nag S, Warner JH, Landwehrmeyer B, Al-Tawil N, Halldin C, Forsberg A, Ware J, Dilda V, Wood A, Sampaio C, Varrone A; PEARL-HD and LONGPDE10 study collaborators. Fazio P, et al. Among authors: fitzer attas cj. Mov Disord. 2020 Apr;35(4):606-615. doi: 10.1002/mds.27963. Epub 2020 Jan 22. Mov Disord. 2020. PMID: 31967355
Biometric monitoring devices for assessing end points in clinical trials: developing an ecosystem.
Arnerić SP, Cedarbaum JM, Khozin S, Papapetropoulos S, Hill DL, Ropacki M, Rhodes J, Dacks PA, Hudson LD, Gordon MF, Kern VD, Romero K, Vradenburg G, Au R, Karlin DR, Facheris MF, Fitzer-Attas CJ, Vitolo OV, Wang J, Miller BM, Kaye JA. Arnerić SP, et al. Among authors: fitzer attas cj. Nat Rev Drug Discov. 2017 Oct;16(10):736. doi: 10.1038/nrd.2017.153. Epub 2017 Sep 22. Nat Rev Drug Discov. 2017. PMID: 28935908 No abstract available.
Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with 18F-MNI-659 and 11C-raclopride with correction for partial volume effect.
Fazio P, Schain M, Mrzljak L, Amini N, Nag S, Al-Tawil N, Fitzer-Attas CJ, Bronzova J, Landwehrmeyer B, Sampaio C, Halldin C, Varrone A. Fazio P, et al. Among authors: fitzer attas cj. Neuroimage. 2017 May 15;152:330-339. doi: 10.1016/j.neuroimage.2017.02.047. Epub 2017 Feb 28. Neuroimage. 2017. PMID: 28254508
33 results